MedPath

Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors

Not Applicable
Completed
Conditions
Stage IIIA Breast Cancer
Stage IV Breast Cancer
Stage I Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage II Breast Cancer
Registration Number
NCT01113554
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

RATIONALE: A breast cancer rehabilitation program and exercise therapy may help improve the quality of life of breast cancer survivors.

PURPOSE: This clinical trial studies a breast cancer rehabilitation program in improving quality of life in breast cancer survivors.

Detailed Description

PRIMARY OBJECTIVES:

I. To estimate accrual, retention, adherence, and participation of breast cancer survivors to a breast cancer rehabilitation program.

II. To estimate the variability of weight, six-minute walk, quality of life and other psychosocial and physical measures in women participating in the BCRP.

SECONDARY OBJECTIVES:

I. To assess changes in the anthropometric, psychosocial, and physical outcomes over the six-month period of the BCRP.

II. To document the types and the rates of adverse events associated with the BCRP.

OUTLINE:

Patients attend exercise therapy sessions over 1 hour 3 times a week for 6 months. Exercise therapy sessions are comprised of a 10 minute warm-up of light stretching and aerobic type exercise (walking, cycling), 30 minutes of endurance type exercise (cycle, walking), and 20 minutes of resistance training exercise.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
26
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Muscular strength6 months
Quality of life6 months
Range of motion6 months
Ability to recruit breast cancer survivors into a six-month breast cancer rehabilitation programApproximately 24 months
BMI6 months
Proportion of screened women who are eligible for the study and the proportion of eligible women who agree to participateApproximately 24 months
Proportion of women who complete the study and the average number of weeks of participationApproximately 24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

Wake Forest University Health Sciences
🇺🇸Winston-Salem, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath